Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy
Maurizio Chiriva‐Internati(Texas Tech University), Everardo Cobos(Texas Tech University), Rosalba Gornati(University of Insubria), Leonardo Mirandola, Martin J. Cannon(University of Arkansas for Medical Sciences), Magda Gioia(University of Rome Tor Vergata), W. Martin Kast(University of Southern California), Giovanni Bernardini(University of Insubria), Marjorie Jenkins(United States Food and Drug Administration), Yuefei Yu(Texas Tech University), Raffaella Chiaramonte(University of Milan)
Cited by 20
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
|The Journal of Immunology|2001|533